semaglutide cease and desist Tong sends letters to Connecticut businesses advertising bootleg GLP-1 weight loss drugs Cease and Desist Letters to

I explore all this in a feature story published today, which marks the kick off of a new series from The Globe and Mail called Skinny Inc, about the big business of weight-loss drugs: Also published today is a companion piece from my colleague Kelly Grant who digs deeper into the research and patient experience of these drugs: We have more coming in the series over the coming weeks, including stories on influencers, insurance coverage, the effect on the food industry and more

MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels

In the SYNERGY-NASH trial, the assessment point was 52 weeks

Pharmacotherapy for obesity: moving towards efficacy improvement

They carry a boxed warning for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Kaiser, Genve (Maladies infectieuses)